These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 23688265
1. Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone. Porter JB, Wood J, Olivieri N, Vichinsky EP, Taher A, Neufeld E, Giardina P, Thompson A, Moore B, Evans P, Kim HY, Macklin EA, Trachtenberg F. J Cardiovasc Magn Reson; 2013 May 20; 15(1):38. PubMed ID: 23688265 [Abstract] [Full Text] [Related]
2. Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy. Pepe A, Meloni A, Rossi G, Cuccia L, D'Ascola GD, Santodirocco M, Cianciulli P, Caruso V, Romeo MA, Filosa A, Pitrolo L, Putti MC, Peluso A, Campisi S, Missere M, Midiri M, Gulino L, Positano V, Lombardi M, Ricchi P. J Cardiovasc Magn Reson; 2013 Jan 16; 15(1):1. PubMed ID: 23324167 [Abstract] [Full Text] [Related]
3. Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload. Smith GC, Alpendurada F, Carpenter JP, Alam MH, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Westwood MA, Galanello R, Roughton M, Pennell DJ. J Cardiovasc Magn Reson; 2011 Jul 06; 13(1):34. PubMed ID: 21733147 [Abstract] [Full Text] [Related]
4. Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major. Alpendurada F, Smith GC, Carpenter JP, Nair SV, Tanner MA, Banya W, Dessi C, Galanello R, Walker JM, Pennell DJ. J Cardiovasc Magn Reson; 2012 Jan 25; 14(1):8. PubMed ID: 22277065 [Abstract] [Full Text] [Related]
5. Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Pibiri M, Nair SV, Walker JM, Pennell DJ. J Cardiovasc Magn Reson; 2008 Feb 25; 10(1):12. PubMed ID: 18298856 [Abstract] [Full Text] [Related]
6. Cardiac events and cardiac T2* in Egyptian children and young adults with beta-thalassemia major taking deferoxamine. Elalfy MS, Abdin IA, El Safy UR, Ibrahim AS, Ebeid FS, Salem DS. Hematol Oncol Stem Cell Ther; 2010 Feb 25; 3(4):174-8. PubMed ID: 21150236 [Abstract] [Full Text] [Related]
7. Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies. Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Magnano C, Rizzo M, Caruso V, Gerardi C, Argento C, Campisi S, Cantella F, Commendatore F, D'Ascola DG, Fidone C, Ciancio A, Galati MC, Giuffrida G, Cingari R, Giugno G, Lombardo T, Prossomariti L, Malizia R, Meo A, Roccamo G, Romeo MA, Violi P, Cianciulli P, Rigano P. Blood Cells Mol Dis; 2009 Feb 25; 42(3):247-51. PubMed ID: 19233692 [Abstract] [Full Text] [Related]
8. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Roughton M, Assomull R, Nair SV, Walker JM, Pennell DJ. Circulation; 2007 Apr 10; 115(14):1876-84. PubMed ID: 17372174 [Abstract] [Full Text] [Related]
9. Comparative efficacy and safety of deferoxamine, deferiprone and deferasirox on severe thalassemia: a meta-analysis of 16 randomized controlled trials. Xia S, Zhang W, Huang L, Jiang H. PLoS One; 2013 Apr 10; 8(12):e82662. PubMed ID: 24376563 [Abstract] [Full Text] [Related]
10. Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone. Lai ME, Grady RW, Vacquer S, Pepe A, Carta MP, Bina P, Sau F, Cianciulli P, Maggio A, Galanello R, Farci P. Blood Cells Mol Dis; 2010 Aug 15; 45(2):136-9. PubMed ID: 20678715 [Abstract] [Full Text] [Related]
11. Effect of combined chelation therapy with deferiprone and deferoxamine on left ventricular diastolic function in adult beta-thalassemia major patients. Tsiapras D, Fragatou S, Farmaki K, Kyrzopoulos S, Paraskevaidis I, Voudris V, Kremastinos D. Hemoglobin; 2010 Jun 15; 34(3):210-20. PubMed ID: 20524811 [Abstract] [Full Text] [Related]
12. A systematic review and meta-analysis of deferiprone monotherapy and in combination with deferoxamine for reduction of iron overload in chronically transfused patients with β-thalassemia. Kuo KH, Mrkobrada M. Hemoglobin; 2014 Jun 15; 38(6):409-21. PubMed ID: 25307964 [Abstract] [Full Text] [Related]
13. Effects of combined deferiprone and deferoxamine chelation therapy on iron load indices in beta-thalassemia. Tsironi M, Assimakopoulos G, Polonofi K, Rigaki K, Aessopos A. Hemoglobin; 2008 Jun 15; 32(1-2):29-34. PubMed ID: 18274980 [Abstract] [Full Text] [Related]
14. Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients. Cassinerio E, Roghi A, Pedrotti P, Brevi F, Zanaboni L, Graziadei G, Pattoneri P, Milazzo A, Cappellini MD. Ann Hematol; 2012 Sep 15; 91(9):1443-9. PubMed ID: 22572843 [Abstract] [Full Text] [Related]
15. Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications. Chuang TY, Li JP, Weng TF, Wu KH, Chao YH. Ann Hematol; 2020 Oct 15; 99(10):2289-2294. PubMed ID: 32737633 [Abstract] [Full Text] [Related]
16. Longitudinal prospective comparison of pancreatic iron by magnetic resonance in thalassemia patients transfusion-dependent since early childhood treated with combination deferiprone-desferrioxamine vs deferiprone or deferasirox monotherapy. Ricchi P, Meloni A, Pistoia L, Gamberini MR, Cuccia L, Allò M, Putti MC, Spasiano A, Rosso R, Cecinati V, Righi R, Renne S, Peritore G, Vallone A, Positano V, Quaia E, Cademartiri F, Pepe A. Blood Transfus; 2024 Jan 15; 22(1):75-85. PubMed ID: 37146300 [Abstract] [Full Text] [Related]
17. Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients. Maggio A, Vitrano A, Lucania G, Capra M, Cuccia L, Gagliardotto F, Pitrolo L, Prossomariti L, Filosa A, Caruso V, Gerardi C, Campisi S, Cianciulli P, Rizzo M, D'Ascola G, Ciancio A, Di Maggio R, Calvaruso G, Pantalone GR, Rigano P. Am J Hematol; 2012 Jul 15; 87(7):732-3. PubMed ID: 22622672 [Abstract] [Full Text] [Related]
18. Pattern of iron chelation therapy in Egyptian beta thalassemic patients: Mansoura University Children's Hospital experience. Abdelrazik N. Hematology; 2007 Dec 15; 12(6):577-85. PubMed ID: 17852442 [Abstract] [Full Text] [Related]
19. Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major. Filosa A, Vitrano A, Rigano P, Calvaruso G, Barone R, Capra M, Cuccia L, Gagliardotto F, Pitrolo L, Prossomariti L, Casale M, Caruso V, Gerardi C, Campisi S, Cianciulli P, Rizzo M, D'Ascola G, Ciancio A, Maggio A. Blood Cells Mol Dis; 2013 Aug 15; 51(2):85-8. PubMed ID: 23628348 [Abstract] [Full Text] [Related]
20. Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients. Pantalone GR, Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud C. Hemoglobin; 2011 Aug 15; 35(3):206-16. PubMed ID: 21599433 [Abstract] [Full Text] [Related] Page: [Next] [New Search]